DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Otieno, M. A.
Right arrow Articles by Anders, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Otieno, M. A.
Right arrow Articles by Anders, M. W.

0090-9556/97/2501-0012-0020$02.00/0
DRUG METABOLISM AND DISPOSITION
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics
Vol. 25, No. 1

Immunolocalization of Microsomal Glutathione S-TraNsferase in Rat Tissues

Monicah A. Otieno, Raymond B. Baggs, John D. Hayes, and M. W. Anders

Departments of Pharmacology and Physiology (M.A.O., M.W.A.) and Laboratory Animal Medicine (R.B.B.), University of Rochester, School of Medicine and Dentistry; and Biomedical Research Center (J.D.H.), University of Dundee, Ninewells Hospital and Medical School

    Abstract
Abstract
Introduction
Results & Discussion
References

Distribution of microsomal glutathione transferase (mGST) protein in rat tissues was investigated by immunohistochemistry. Studies on the localization of mGST are of interest because of its involvement in the detoxication and bioactivation of xenobiotics. mGST antigen was detected in the cytoplasm of some hepatocytes and in bile ducts. In kidney, focal staining of mGST was observed in distal tubules and collecting ducts. Cerebral cortical and cerebellar Purkinje neurons showed good immunoreactivity, and nuclear staining was observed in the choroid plexus. The antigen was detected in epithelial cells of respiratory bronchioles and in the crypt cells of the duodenum. Exocrine cells of the pancreas stained for mGST. Nuclear immunostaining for this protein was observed in primary spermatocytes. mGST antigen was detected in the cytoplasm of the adrenal medulla as a granular stain. Leydig and Sertoli cells in testis also stained for the antigen. Distribution of mGST protein differs from that observed with cytosolic transferases and may be important in determining cell-selective susceptibility to xenobiotics.

    Introduction
Abstract
Introduction
Results & Discussion
References

Glutathione transferases (E.C. 2.5.1.18) catalyze the reaction of glutathione with a range of xenobiotic and endogenous electrophiles (1-3). Multiple GSTs1 exist, and at least 20 GST genes have been identified in the rat (4). Demonstration of the tissue-selective expression and subcellular localization of cytosolic GSTs has improved the understanding of their role in xenobiotic disposition and has provided strategies for assessing tissue-selective cell damage (5, 6).

Both soluble and membrane-bound GSTs have been identified. Cytosolic GST isoenzymes are a family of homo- and heterodimeric proteins that are grouped into five classes (alpha , µ, pi , sigma , and theta ) based on primary structure, substrate selectivity, sensitivity to inhibitors, and immunological properties (2, 7). Soluble GSTs are present in mitochondria, and a unique theta -class (GST 13-13, now called GST T3*-3*) has been isolated from mitochondrial matrices (8-10).

The role of the GSTs in the detoxication of electrophilic chemicals and metabolites is well characterized (1). In addition, the glutathione-dependent bioactivation of a range of xenobiotics---including vicinal dihaloalkanes (11), isocyanates and isothiocyanates (12), quinones (13), and haloalkenes (14)---is catalyzed by GSTs.

Membrane-bound mGST is a homotrimeric protein that is structurally and immunologically distinct from the cytosolic transferases and is classified separately (2, 7). mGST differs from the cytosolic GSTs in that it can be activated several-fold by sulfhydryl reagents, such as N-ethylmaleimide; this property has been exploited to obtain purified mGST that is not contaminated with cytosolic GSTs (15). Leukotriene C4 synthesis is catalyzed by a membrane-bound GST that is distinct from the N-ethylmaleimide-activatable mGST, as well as from the alpha -, µ-, pi -, sigma -, and theta -classes of cytosolic GSTs (16).

Human and rat liver microsomal glutathione transferases have been cloned, and the cDNA sequences share 77% identity in the coding region (17). Ontogeny of mGST and the structural organization of human mGST gene have recently been reported (18, 19). Antibodies raised against the human and rat mGSTs cross-react (20).

mGST catalyzes the reaction of glutathione with a range of electrophilic compounds, and its activity as a selenium-independent peroxidase may be an important cytoprotective function (21). Oxidants and oxidative stress activate the mGST (22), which may also contribute to its cytoprotective actions. In addition to its cytoprotective action, mGST catalyzes the first step in the glutathione- and cysteine conjugate beta -lyase-dependent bioactivation of nephrotoxic haloalkenes (14). mGST activity is present in various rat organs, and the highest activity is present in the liver and testes (23). Although activity in whole-organ homogenates may be relatively low, mGST activity may be high in some cell populations and may, thereby, contribute to xenobiotic detoxication or bioactivation. The objective of this study was to examine the cellular localization of mGST in various rat organs by immunohistochemistry.

Methods

Tissue Preparations. Fischer 344 rats (200-250 g; Charles River Breeding Laboratories, Inc., Wilmington, MA) were used. Rats were anesthetized with sodium pentobarbital:chloral hydrate (50 mg/kg:250 mg/kg, ip) and perfused through the left ventricle with PBS, followed by 10% neutral-buffered formalin. Organs were removed, fixed in 10% buffered formalin, and embedded in paraffin. Sections (5 µm) were prepared and mounted on poly-L-lysine-coated slides.

Western Blotting. mGST was purified from the microsomal fraction of human liver by a combination of hydroxyapatite, gel filtration, and CM-cellulose chromatography (20). Female New Zealand white rabbits were each initially immunized with 200 µg of purified mGST in complete Freund's adjuvant, which was followed 6 weeks later by another inoculation with 200 µg of mGST in incomplete Freund's adjuvant (24). Animals were bled 2 weeks after the second inoculation, and serum was prepared. After the addition of sodium azide to a final concentration of 0.1%, serum was stored at -70°C until used. Microsomal fractions were prepared as described previously (25). Protein samples (2-10 µg) were loaded on 10% (w/v) polyacrylamide gels and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis with a Protein mini-gel apparatus (Bio-Rad Laboratories, Richmond, CA). Proteins were transferred to nitrocellulose membranes (Bio-Rad Laboratories) with a LKB Transphor electroblotting unit (LKB, Gaithersburg, MD). Membranes were treated with blocking solution [7.5% (w/v) nonfat dry milk in 20 mM Tris HCl, 150 mM NaCl, and 0.15% (w/v) Tween 20 (pH 7.4)] for 16 hr, followed by incubation with primary antibody (diluted 1:1,000 in blocking solution) for 7 hr. Membranes were incubated for 1 hr with alkaline phosphatase-linked goat anti-rabbit secondary antibody diluted 1:1,000 in a mixture of 20 mM Tris HCl, 150 mM NaCl, and 0.15% (w/v) Tween 20 (pH 7.4). All incubations were conducted at room temperature, and membranes were washed three times with a mixture of 20 mM Tris HCl, 150 mM NaCl, and 0.15% (w/v) Tween 20 (pH 7.4) for 10 min between each step. Immunoreactive bands were detected with 0.3 mg/ml nitro blue tetrazolium and 0.15 mg/ml 5-bromo-4-chloro-3-indoloyl phosphate in 100 mM Tris buffer (pH 9.5) containing 5 mM MgCl2.

Immunohistochemistry. The avidin-biotin complex staining method (Vector Laboratories, Inc., Burlingame, CA) was used according to the manufacturer's directions to localize mGST in paraffin-embedded tissue sections. Primary antibodies or preimmune serum were diluted 1:1000 in a solution of 0.4% Triton X-100 and 1% bovine serum albumin in PBS. Secondary antibodies were diluted in PBS.

Paraffin was removed from the sections by immersion in xylene, and sections were rehydrated by immersion in graded, decreasing concentrations of ethanol in water. Endogenous peroxidase activity was quenched by incubating the slides for 5 min in a solution of 3% H2O2 and 10% methanol in PBS; sections were washed twice with a solution of 0.02% Triton X-100 in PBS for 15 min. Slides were incubated with preimmune serum or primary antibodies (1:1,000) for 48 hr at 4°C, followed by incubation with the biotinylated goat anti-rabbit secondary antibody (Vector Laboratories) for 1 hr at room temperature. Horseradish-peroxidase-conjugated avidin-biotin complex (Vectastain Elite Kit, Vector Laboratories) was diluted and prepared according to the manufacturer's directions, and sections were incubated in this mixture for 1 hr. Between each step, slides were incubated twice with a solution of 0.02% Triton X-100 in PBS for 15 min at room temperature. Before detection of the antigen, the slides were rinsed three times with 0.05 M Tris-buffered saline (pH 7.2). Detection with diaminobenzidine or 3-amino-9-ethylcarbazole was done according to the manufacturer's directions (Vector Laboratories). Slides stained with diaminobenzidine were counterstained with hematoxylin, dehydrated, and mounted in an organic mounting medium (Permount; Fisher Scientific, Fair Lawn, NJ); slides treated with 3-amino-9-ethylcarbazole were also counterstained with hematoxylin, but were mounted in an aqueous mount (Aqua-polymount; Polysciences, Inc., Warrington, PA).

    Results and Discussion
Abstract
Introduction
Results & Discussion
References

This study represents the first immunohistochemical description of the comparative distribution of mGST protein in rat tissues. mGST antigen was detected in differing amounts in the organs studied by immunoblotting and immunohistochemistry.

Immunoblotting studies with human anti-mGST antibodies showed the presence of a single protein band of identical mobility in microsomal fractions from rat liver, testis, kidney, and lung (fig. 1). The immunoreactive band displayed a mobility consistent with its identity as mGST and was estimated to have a molecular mass of ~17 kDa; the calculated molecular mass of rat liver mGST is 17,430 Da (17). Furthermore, antibodies yielded a single band in the immunoblots, indicating selectivity for mGST. Antibodies raised against the mGST do not cross-react with cytosolic GSTs (15). (Because the amount of mGST protein in the tissues studied differed, the amount of protein applied to the gel varied with the tissue being studied; fig. 1 cannot be used to compare the relative amounts of mGST in various tissues.)


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 1.   Identification of mGST in rat microsomal fractions by Western blotting.

Samples of liver (lanes 1 and 2, 2 µg protein), lung (lanes 3 and 4, 10 µg protein), kidney (lanes 5 and 6, 10 µg protein), and testes (lanes 7 and 8, 10 µg protein) were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting, as described in Materials and Methods. Mobility of the molecular weight marker (lysozyme, 17.9 kDa) is also shown.

Cellular localization of mGST protein in various rat organs was studied by immunohistochemistry. A comparison of the localization of mGST found in this study and that reported for other rat and human cytosolic GSTs is summarized in table 1.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1
Summary of the distribution of cytosolic and mGST antigen in various rat and human tissues

The presence or absence of mGST antigen, as determined in the present study, and of cytosolic GSTs in rat and human tissues, as reported in the cited references and as determined by immunohistochemistry, are shown herein.

In the liver, mGST antigen was demonstrable as a faintly granular cytoplasmic material in most, but not all, hepatocytes (fig. 2A). Staining was occasionally intense in individual hepatocytes (fig. 2E, arrow), but adjacent clusters of hepatocytes seemed to lack detectable antigen (fig. 2A, arrow). Staining tended to be more intense in centrilobular regions than in periportal regions. The reason for the uneven distribution of mGST protein in hepatocytes is not clear. mGST was detected in the cytoplasm and not in nuclei of hepatocytes, which is in agreement with previously reported results with human tissues (26). Both nuclear and cytoplasmic detection of GST-alpha in hepatocytes has been previously reported (27, 28). In the portal triad, cytoplasmic components of the bile duct epithelium were well stained (fig. 2C). GSTs have the capacity to bind a wide range of lipophilic compounds, including bile acids and bilirubin (29, 30). mGST in the biliary epithelium may serve as a carrier protein for the transport of such molecules, as well as function to detoxify xenobiotics. Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 2, B, D, and F).


View larger version (156K):
[in this window]
[in a new window]
 
Fig. 2.   Immunohistochemical detection of mGST protein in rat liver.

Liver sections were incubated with polyclonal anti-mGST antibodies (A, C, and E) or with preimmune serum (B, D, and E) and stained by the avidin-biotin complex procedure with a final chromogen of 3-amino-9-ethylcarbazole, as described in Materials and Methods. (A) Note the occasional, poorly stained hepatocytes (arrow). T, Portal triad; c, central vein. Original magnification 100×; bar = 100 µm. (C) Higher magnification 200×; bar = 50 µm) of centrilobular area. Note the intensely stained cell (arrow). T, Portal triad; c, Central vein. (E) Higher magnification 200×; bar = 50 µm) of portal triad. Note that the bile duct epithelial cells show both cytoplasmic and nuclear staining. b, bile duct.

Immunohistochemical observation of mGST protein in hepatocytes is consistent with the observation that hepatic mGST activity exerts a cytoprotective function by providing glutathione-dependent detoxication against lipid peroxidation (21, 31). Hepatic mGST also catalyzes the first step in the glutathione- and beta -lyase-dependent bioactivation of nephrotoxic haloalkenes. Also, in rat hepatocytes, 85% of glutathione-conjugate formation with chlorotrifluoroethene as the substrate is catalyzed by mGST (32). Hexafluoropropene is converted to S-(1,1,2,3,3,3-hexafluoropropyl)glutathione in rat hepatic cytosolic fractions and to S-(1,2,3,3,3-pentafluoropropenyl)glutathione in rat hepatic microsomal fractions, but total conjugate formation is greater in microsomes than in cytosol (33).

Other immunohistochemical studies show the presence of alpha -, µ-, and theta -class GSTs in rat liver hepatocytes. Like mGSTs, staining was more intense in the centrilobular region than in the midzonal or perioportal regions (34). GST-pi is not seen in adult hepatocytes, but, like µ- and theta -class GSTs, it is expressed in biliary epithelium (27, 28, 35). GST-alpha is not present in bile ducts (28).

In the renal cortex, the most intense staining for mGST antigen was observed in the distal convoluted tubules (fig. 3). Faint staining was observed in some glomerular cells, and the proximal convoluted tubules demonstrated light apical staining, but none was demonstrable in the brush border (fig. 3A). Collecting ducts in the cortex and medulla were well stained (fig. 3C). Thick portions of the loop of Henle were stained intensely (fig. 3E). Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 3, B, D, and F).


View larger version (163K):
[in this window]
[in a new window]
 
Fig. 3.   Immunohistochemical detection of mGST protein in rat kidney.

Sections were incubated with polyclonal anti-mGST antibodies (A, C, and E) or with preimmune serum (B, D, and E) and stained by the avidin-biotin complex procedure with a final chromogen of 3-amino-9-ethylcarbazole, as described in Materials and Methods. (A) In the renal cortex, the most intense staining was observed in the distal convoluted tubules (D). Glomeruli (G) were faintly stained, and proximal convoluted tubules (P) demonstrated very light apical staining; no staining was observed in the brush border. Original magnification 200×; bar = 50 µm. (C) Collecting ducts (CD) in the cortex and medulla were well stained. Original magnification 200×; bar = 50 µm. (E) The thick portions of the loop of Henle (L) stained intensely. Original magnification 100×; bar = 100 µm.

GST-alpha is selectively expressed in renal proximal tubules and in the thick descending section of the loop of Henle, whereas GST-µ and -pi are expressed selectively in the thin loop of Henle, distal convoluted tubules, and collecting ducts (5, 28, 35-37). Focal localization of mGST antigen in the distal tubules and collecting ducts and of GST-alpha in the proximal tubules demonstrates the ubiquitous distribution of GSTs throughout the nephron.

The presence of GSTs in the kidney is well established (38). Renal glutathione-conjugate formation has been detected in isolated rabbit renal proximal tubules with chlorotrifluoroethene as the substrate, although the enzyme that catalyzes the reaction was not identified (39). Renal cytosolic fractions, but not renal microsomal fractions, catalyze the conversion of hexafluoropropene to S-(1,1,2,3,3,3-hexafluoropropyl)glutathione, but S-(1,2,3,3,3-pentafluoropropenyl)glutathione formation was not detected in kidney cytosol or microsomes.

The release of GST-alpha from its proximal tubular location and its detection in urine has previously been used as a diagnostic measure of renal tubular damage in cyclosporin-induced nephrotoxicity (40, 41). Use of GST-pi in urine, as a marker of renal tubular injury, has also been reported (42, 43). S-(1,2-Dichlorovinyl)-L-cysteine is selectively toxic to the S3 segment of the proximal tubule and is an example of renal toxins that target specific segments of the renal tubules, leaving other segments unharmed. Selective markers for renal tubular injury are useful diagnostic tools for such toxins. As has been demonstrated for GST-alpha and -pi , focal localization of mGST makes it a potentially suitable candidate as a marker for distal tubular injury; in addition the lack of immunoreactivity of anti-mGST antibodies with cytosolic GSTs (15) is a property that could be exploited to design sensitive assays that would distinguish it from other GSTs also used as markers.

mGST protein was also detected in the brain (fig. 4). Choroid epithelial cells were intensely stained (fig. 4A, arrow), and abundant antigen was detected in both the nucleus and cytoplasm. Neuronal nuclei in the cerebral cortex were well stained (fig. 4C), as were cerebellar Purkinje neurons and the molecular-layer neurophil (fig. 4E). Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 4, B, D, and F).


View larger version (140K):
[in this window]
[in a new window]
 
Fig. 4.   Immunohistochemical detection of mGST protein in rat brain.

Sections were incubated with polyclonal anti-mGST antibodies (A, C, and E) or with preimmune serum (B, D, and F) and stained by the avidin-biotin complex procedure with a final chromogen of diaminobenzidine, as described in Materials and Methods. (A) Lateral ventricle with well-stained choroid-plexis epithelial cells (arrow). lv, Lateral ventricle. Original magnification 100×; bar = 100 µm. (C) Cerebral cortex with abundant nuclear staining of cortical neurons (arrow). Original magnification 200×; bar = 50 µm. (E) Cerebellar cortex with abundant nuclear staining of Purkinje neurons and the molecular layer neurophil (arrow). Original magnification 200×; bar = 50 µm.

In human brains, GST-alpha and -pi have not been detected in neurons, but weak staining is observed with GST-pi in glial cells (27, 28, 44). However, studies with rat brain show nuclear localization of GST-alpha in Purkinje cells and neurons in the brainstem, hippocampus, and cerebral cortex (45). Immunohistochemical studies with rat µ-class GSTs show that the protein is localized in the glial cells lining the ventricles and in astrocyte endfeet and processes (46).

GST activity is much higher in cultured chick astrocytes than in neurons or forebrain (47). Whole-brain mGST activity is much lower (~6%) than liver mGST activity (23).

Glutathione-dependent conjugation in brain cytosol has been demonstrated with the neurotoxin acrylamide (48). There is also evidence that brain GSTs can bind hormones and neurotransmitters (46). The role of mGST in the nucleus is to be determined. Glutathione peroxidase activity of GSTs has been postulated to play a role in the detoxication of peroxidized DNA, and mGST has been shown to protect against lipid peroxidation. mGST may play a significant role in detoxifying peroxides in the nucleus, because selenium-dependent glutathione peroxidase activity is low in this organelle (49, 50). Bennett et al. (51) have also reported that the DNA-binding protein, protein BA that colocalizes with U-snRNPs in the cell nucleus is a glutathione transferase.

In lung tissue, there was scanty, focal presence of antigen in the epithelial cells of the terminal respiratory bronchioles, most notably in the apical portions, and alveolar epithelial cells showed little detectable cytoplasmic antigen (fig. 5A). Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 5B).


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 5.   Immunohistochemical detection of mGST protein in rat lung.

Sections were incubated with polyclonal anti-mGST antibodies (A) or with preimmune serum (B) and stained by the avidin-biotin complex procedure with a final chromogen of 3-amino-9-ethylcarbazole, as described in Materials and Methods. (A) Terminal bronchiolar epithelium (tb) showed scanty apical staining (arrow). Alveolar duct (ad) and alveolar epithelium showed scanty staining. (B) Control section incubated with preimmune serum. Original magnification 200×; bar = 50 µm.

mGST activity in lung is 12% of that found in liver (23). Lung mGST may play a role in the bioactivation of xenobiotics: Patel et al. (52) found that, of the extrahepatic tissues studied, lung microsomes had the highest activity toward dichloroacetylene, a neurotoxin, nephrotoxin, and nephrocarcinogen. Activity was not observed in the lung cytosol.

Proteins corresponding to alpha - and µ-class GSTs have been purified from rat lung (53). GST-alpha protein was not detected in the epithelial cells of the lung or bronchi (28). In contrast, Anttila et al. (54) reported localization of all GST classes in the bronchial epithelium. Others have detected GST-pi in ciliated epithelial cells and GST-alpha , -µ, and -pi in Clara cells (55).

In the intestinal tract, duodenal tissue was also examined for the presence of mGST antigen. Staining was most intense in the apical portions (brush border) of the enteric epithelial cells, particularly in the cryptal areas (fig. 6A). Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 6B). Specific activity of mGST in rat intestine is 48% of that present in the liver (23).


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 6.   Immunohistochemical detection of mGST protein in rat duodenum.

Sections were incubated with polyclonal anti-mGST antibodies (A) or with preimmune serum (B) and stained by the avidin-biotin complex procedure with a final chromogen of 3-amino-9-ethylcarbazole, as described in Materials and Methods. (A) Note brush-border staining in the crypts (arrows). (B) Section incubated with preimmune serum. Original magnification 200×; bar = 50 µm.

In the rat intestine, GST activity is highest in the duodenum and jejunum (56, 57). GST-pi is expressed at significant levels in the duodenum (28).

In pancreatic tissue, the Islets of Langerhans lacked antigen (fig. 7A). Exocrine epithelial cells contained some antigen, most notably in the apical portions of epithelial cells. Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 7B).


View larger version (83K):
[in this window]
[in a new window]
 
Fig. 7.   Immunohistochemical detection of mGST protein in rat pancreas.

Sections were incubated with polyclonal anti-mGST antibodies (A) or with preimmune serum (B) and stained by the avidin-biotin complex procedure with a final chromogen of 3-amino-9-ethylcarbazole, as described in Materials and Methods. (A) Note granular staining of the apical portions of the exocrine cells (arrow). IS, Islets of Langerhans. (B) Section incubated with preimmune serum. Original magnification 200×; bar = 50 µm.

GST-alpha and GST-pi antigens have not been detected in the Islets of Langerhans (27, 35). GST-alpha has been detected in the cytoplasm of acinar cells, whereas GST-pi is present in both the cytoplasm and some nuclei of these cells in rat pancreas (58).

Cells of the adrenal cortex showed little staining, but medullary cells contained variable amounts of faintly staining granular material in the cytoplasms (fig. 8A). Occasional cells contained abundant antigen, but adjacent cells showed scanty stainable material. Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 8B). Specific activity of mGST in rat adrenal is 41% of that found in the liver (23).


View larger version (81K):
[in this window]
[in a new window]
 
Fig. 8.   Immunohistochemical detection of mGST protein in rat adrenal gland.

Sections were incubated with polyclonal anti-mGST antibodies (A) or with preimmune serum (B) and stained by the avidin-biotin complex procedure with a final chromogen of 3-amino-9-ethylcarbazole, as described in Materials and Methods. (A) Note the cell with moderate cytoplasmic granular antigen (arrow). C, cortex; M, medulla. (B) Section incubated with preimmune serum. Original magnification 200×; bar = 50 µm.

GST-alpha protein is found in the zona reticularis of the adrenal cortex, but not in the outer layers of the cortex or medulla (28). GST-pi was detected faintly in both layers (27).

In the testes, the interstitial cells showed modest cytoplasmic and nuclear staining (fig. 9A). All stages of sperm-cell maturation were stained in the seminiferous tubules, and staining was pronounced in the nuclei of primary spermatocytes. Nonspecific staining was not observed in sections incubated with preimmune serum (fig. 9B).


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 9.   Immunohistochemical detection of mGST protein in rat testes.

Sections were incubated with polyclonal anti-mGST antibodies (A) or with preimmune serum (B) and stained by the avidin-biotin complex procedure with a final chromogen of diaminobenzidine, as described in Materials and Methods. (A) Interstitial cells of Leydig (L) show moderate, variable cytoplasmic staining (small arrow), and the seminiferous spermatocytes show abundant nuclear staining (bold arrow). Open arrow, Sertoli cells. (B) Section incubated with preimmune serum. Original magnification 200×; bar = 50 µm.

Activity studies show that the specific activity of mGST in rat testis is similar to that in the liver (23), but a physiological role for mGST in the testis has not been established. Peroxidative DNA damage has been observed in proliferating cells (3) and, because mGST shows peroxidase activity (59), it is possible to speculate that testicular mGST may function to reduce damage to DNA caused by oxidative stress.

Immunohistochemical studies with cytosolic GSTs show the presence of all GST classes in Leydig cells in the testis; GST-alpha and GST-µ were detected in Sertoli cells, whereas all stages of sperm-cell maturation were unreactive to antibodies against alpha -, pi -, or µ-class GSTs (27, 28, 60, 61). Distribution of GSTs along the rat epididymis seems to be region-specific; recent evidence shows selective expression of GST-pi in basal cells of the epididymal epithelium (62). Basal cells have been proposed to play an active role in detoxication in the epididymis, thus further demonstrating the cytoprotective role that GSTs may play in the testis. Finally, the presence of µ- and alpha -class GSTs in testicular microsomes has recently been reported (63).

Present studies show that the distribution of mGST protein differs from that of cytosolic GSTs that have been studied. Both mGST and cytosolic GSTs play important roles in xenobiotic detoxication and bioactivation. As described previously, peroxidative activity of mGST may exert a detoxification function in testes. mGST is important in the bioactivation of nephrotoxic haloalkenes. Several haloalkenes are selective nephrotoxins and undergo glutathione and cysteine conjugate beta -lyase-dependent bioactivation (14, 64, 65). Biotransformation of haloalkenes to glutathione conjugates is preferentially catalyzed by hepatic mGST (32). Present findings show the presence of small amounts of mGST antigen in renal proximal tubules, which is consistent with the observation that mGST activity is much lower in the kidney than in the liver (23). As described previously, studies with chlorotrifluoroethene show that ~85% of hepatic glutathione conjugate formation is catalyzed by mGST (32).

Immunohistochemical studies reported herein demonstrate unique patterns of distribution of mGST protein across organs and show that the distribution pattern seen with mGST differs from the patterns seen with most cytosolic transferases, although there are some similarities between the distribution of mGST and GST-alpha . Distribution of GST activities may play a role in determining the susceptibility of a tissue or cell type to different xenobiotics, because mGST and cytosolic GSTs have different, but overlapping, substrate selectivities.

    Footnotes

Received June 21, 1996; accepted September 27, 1996.

   This study was supported by the National Institute of Environmental Health Sciences Grant ES03127 (to M.W.A.).

Send reprint requests to: Dr. M. W. Anders, Department of Pharmacology and Physiology, University of Rochester, 601 Elmwood Avenue, Box 711, Rochester, NY 14642.

    Abbreviations

Abbreviations used are: GST, glutathione transferase; mGST, microsomal glutathione transferase; PBS, phosphate-buffered saline.

    References
Abstract
Introduction
Results & Discussion
References

1. L. F. Chasseaud: The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv. Cancer Res.  29, 175-274 (1979)[Medline].
2. B. Mannervik and M. Widersten: Human glutathione transferases: classification, tissue distribution, structure, and functional properties. In "Advances in Drug Metabolism in Man" (G. M. Pacifici and G. N. Fracchia, eds.), pp. 407-459. Commission of the European Communities, Luxembourg, 1995.
3. B. Ketterer and L. G. Christodoulides: Enzymology of the cytosolic glutathione S-transferases. Adv. Pharmacol.  27, 37-69 (1994).
4. J. D. Hayes and D. J. Pulford: The glutathione S-transferase supergene family: regulation of GST and the contribution of isoenzymes to cancer chemoprotection and drug resistance. CRC Crit. Rev. Biochem. Mol. Biol.  30, 445-600 (1995).
5. D. J. Harrison, R. Kharbanda, D. S. Cunningham, L. I. McLellan, and J. D. Hayes: Distribution of glutathione S-transferase isoenzymes in human kidney: basis for possible markers of renal injury. J. Clin. Pathol.  42, 624-628 (1989)[Abstract/Free Full Text].
6. A. Sundberg, E. L. Appelkvist, G. Dallner, and R. Nilsson: Glutathione transferases in the urine: sensitive methods for detection of kidney damage induced by nephrotoxic agents in humans. Environ. Health Perspect. 102 (Suppl. 3), 293-296 (1994).
7. B. Mannervik and U. H. Danielson: Glutathione transferases---structure and catalytic activity. CRC Crit. Rev. Biochem.  23, 281-334 (1988).
8. P. Kraus: Resolution, purification and some properties of three glutathione transferases from rat liver mitochondria. Hoppe-Seyler's Z. Physiol. Chem.  361, 9-15 (1980)[Medline].
9. C. M. Ryle and T. J. Mantle: Studies on the glutathione S-transferase activity associated with rat liver mitochondria. Biochem. J.  222, 553-556 (1984)[Medline].
10. J. M. Harris, D. J. Meyer, B. Coles, and B. Ketterer: A novel glutathione transferase (13-13) isolated from the matrix of rat liver mitochondria having structural similarity to class theta enzymes. Biochem. J.  278, 137-141 (1991).
11. F. P. Guengerich: Metabolism and genotoxicity of dihaloalkanes. Adv. Pharmacol.  27, 211-236 (1994).
12. T. A. Baillie and K. Kassahun: Reversibility in glutathione-conjugate formation. Adv. Pharmacol.  27, 165-183 (1994).
13. T. J. Monks and S. S. Lau: Glutathione conjugates as a mechanism for the transport of reactive metabolites. Adv. Pharmacol.  27, 183-210 (1994).
14. W. Dekant, S. Vamvakas, and M. W. Anders: Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: cysteine conjugate beta -lyase pathway. Adv. Pharmacol.  27, 115-162 (1994).
15. C. Andersson, E. Mosialou, R. Weinander, and R. Morgenstern: Enzymology of microsomal glutathione S-transferase. Adv. Pharmacol.  27, 19-35 (1994).
16. M. Söderström, S. Hammarström, and B. Mannervik: Leukotriene C synthase in mouse mastocytoma cells. Biochem. J.  250, 713-718 (1988)[Medline].
17. J. L. DeJong, R. Morgenstern, H. Jörnvall, J. W. DePierre, and C.-P. D. Tu: Gene expression of rat and human microsomal glutathione S-transferases. J. Biol. Chem.  263, 8430-8436 (1988)[Abstract/Free Full Text].
18. G. Lundqvist and R. Morgenstern: Ontogenesis of rat liver microsomal glutathione transferase. Biochem. Pharmacol.  50, 421-423 (1995)[Medline].
19. M. J. Kelner, M. N. Stokely, N. E. Stovall, and M. A. Montoya: Structural organization of the human microsomal glutathione S-transferase gene (GST12). Genomics, in press.
20. L. I. McLellan, C. R. Wolf, and J. D. Hayes: Human microsomal glutathione S-transferase. Its involvement in the conjugation of hexachloro-1,3-butadiene with glutathione. Biochem. J.  258, 87-93 (1989)[Medline].
21. E. Mosialou, G. Ekstrom, A. E. P. Adang, and R. Morgenstern: Evidence that rat liver microsomal glutathione transferase is responsible for glutathione-dependent protection against lipid peroxidation. Biochem. Pharmacol.  45, 1645-1651 (1993)[Medline].
22. Y. Aniya and M. W. Anders: Activation of rat liver microsomal glutathione S-transferase by reduced oxygen species. J. Biol. Chem.  264, 1998-2002 (1989)[Abstract/Free Full Text].
23. R. Morgenstern, G. Lundqvist, G. Andersson, L. Balk, and J. W. DePierre: The distribution of microsomal glutathione transferase among different organelles, different organs, and different organisms. Biochem. Pharmacol.  33, 3609-3614 (1984)[Medline].
24. J. D. Hayes and T. J. Mantle: Use of immuno-blot techniques to discriminate between the glutathione S-transferase Yf, Yk, Ya, Yn/Yb and Yc subunits and to study their distribution in extrahepatic tissues. Biochem. J.  233, 779-788 (1986)[Medline].
25. E. Tanaka and M. W. Anders: Biosynthesis of S-(2-chloro-1,1,2-trifluoroethyl)glutathione in rat and human hepatocytes and in Hep G2 cells. Drug Metab. Dispos.  23, 48-54 (1995)[Abstract].
26. P. C. Hayes, D. J. Harrison, I. A. D. Bouchier, L. I. McLellan, and J. D. Hayes: Cytosolic and microsomal glutathione S-transferase isoenzymes in normal human liver and intestinal epithelium. Gut  30, 854-859 (1989)[Abstract/Free Full Text].
27. J. A. H. Campbell, A. V. Corrigall, A. Guy, and R. E. Kirsch: Immunohistologic localization of alpha, mu, and pi class glutathione S-transferases in human tissues. Cancer  67, 1608-1613 (1991)[Medline].
28. A. G. M. Sundberg, R. Nilsson, E.-L. Appelkvist, and G. Dallner: Immunohistochemical localization of alpha  and pi  class glutathione transferases in normal human tissues. Pharmacol. Toxicol.  72, 321-331 (1993)[Medline].
29. K. Kamisaka, I. Listowsky, Z. Gatmaitan, and I. M. Arias: Interactions of bilirubin and other ligands with ligandin. Biochemistry  14, 2175-2180 (1975)[Medline].
30. H. Maruyama and I. Listowsky: Preferential binding of steroids by anionic forms of rat glutathione S-transferase. J. Biol. Chem.  259, 12449-12455 (1984)[Abstract/Free Full Text].
31. E. Mosialou and R. Morgenstern: Activity of rat liver microsomal glutathione transferase towards products of lipid peroxidation and studies on the effect of inhibitors on glutathione-dependent protection against lipid peroxidation. Arch. Biochem. Biophys.  275, 289-294 (1989)[Medline].
32. S. J. Hargus, M. E. Fitzsimmons, Y. Aniya, and M. W. Anders: Stereochemistry of the microsomal glutathione S-transferase catalyzed addition of glutathione to chlorotrifluoroethene. Biochemistry  30, 717-721 (1991)[Medline].
33. M. Koob and W. Dekant: Metabolism of hexafluoropropene. Evidence for bioactivation by glutathione conjugate formation in the kidney. Drug. Metab. Dispos.  18, 911-916 (1990)[Abstract].
34. J. A. Redick, W. B. Jakoby, and J. Baron: Immunohistochemical localization of glutathione S-transferases in livers of untreated rats. J. Biol. Chem.  257, 15200-15203 (1982)[Abstract/Free Full Text].
35. P. Terrier, A. J. Townsend, J. M. Coindre, T. J. Triches, and K. H. Cowan: An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am. J. Pathol.  137, 845-853 (1990)[Abstract].
36. B. Rozell, H.-A. Hansson, C. Guthenberg, M. K. Tahir, and B. Mannervik: Glutathione transferases of classes alpha , µ and pi  show selective expression in different regions of rat kidney. Xenobiotica  23, 835-849 (1993)[Medline].
37. L. H. Overby, S. Gardlik, R. M. Philpot, and C. J. Serabjit-Singh: Unique distribution profiles of glutathione S-transferases in regions of kidney, ureter, and bladder of rabbit. Lab. Invest.  70, 468-478 (1994)[Medline].
38. M. W. Anders and W. Dekant: Renal xenobiotic metabolism: Role in bioactivation of nephrotoxic xenobiotics. In "Renal Disposition and Nephrotoxicity of Xenobiotics" (M. W. Anders, W. Dekant, D. Henschler, H. Oberleithner and S. Silbernagl, eds.), pp. 155-183. Academic Press, San Diego, 1993.
39. C. D. Hassall, A. J. Gandolfi, R. C. Duhamel, and K. Brendel: The formation and biotransformation of cysteine conjugates of halogenated ethylenes by rabbit renal tubules. Chem.-Biol. Interact.  49, 283-297 (1984)[Medline].
40. L. Bäckman, E.-L. Appelkvist, O. Ringdén, and G. Dallner: Glutathione transferase in the urine: a marker for post-transplant tubular lesions. Kidney Int.  33, 571-577 (1988)[Medline].
41. L. Bäckman, E. L. Appelkvist, O. Ringdén, and G. Dallner: Urinary levels of basic glutathione transferase as an indicator of proximal tubular damage in renal transplant recipients. Transplant. Proc.  21, 1514-1516 (1989)[Medline].
42. A. G. Sundberg, E. L. Appelkvist, L. Backman, and G. Dallner: Urinary pi-class glutathione transferase as an indicator of tubular damage in the human kidney. Nephron  67, 308-316 (1994)[Medline].
43. A. G. Sundberg, E. L. Appelkvist, L. Backman, and G. Dallner: Quantitation of glutathione transferase-pi in the urine by radioimmunoassay. Nephron  66, 162-169 (1994)[Medline].
44. P. J. Carder, R. Hume, A. A. Fryer, R. C. Strange, J. Lauder, and J. E. Bell: Glutathione S-transferase in human brain. Neuropathol. Appl. Neurobiol.  16, 293-303 (1990)[Medline].
45. J. A. Johnson, A. El Barbary, S. E. Kornguth, J. F. Brugge, and F. L. Siegel: Glutathione S-transferase isoenzymes in rat brain neurons and glia. J. Neurosci.  13, 2013-2023 (1993)[Abstract].
46. M. Abramovitz, H. Homma, S. Ishigaki, F. Tansey, W. Cammer, and I. Listowsky: Characterization and localization of glutathione-S-transferases in rat brain and binding of hormones, neurotransmitters, and drugs. J. Neurochem.  50, 50-57 (1988)[Medline].
47. T. K. Makar, M. Nedergaard, A. Preuss, A. S. Gelbard, A. S. Perumal, and A. J. L. Cooper: Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes plan an important role in antioxidative processes in the brain. J. Neurochem.  62, 45-53 (1994)[Medline].
48. R. Dixit, H. Mukhtar, P. K. Seth, and C. R. Krishna Murti: Conjugation of acrylamide with glutathione catalysed by glutathione-S-transferases of rat liver and brain. Biochem. Pharmacol.  30, 1739-1744 (1981)[Medline].
49. B. Ketterer and D. J. Meyer: Glutathione transferases: a possible role in the detoxication and repair of DNA and lipid hydroperoxides. Mutat. Res.  214, 33-40 (1989)[Medline].
50. E. Mosialou, F. Piemonte, C. Andersson, R. M. E. Vos, P. J. Van Bladeren, and R. Morgenstern: Microsomal glutathione transferase: lipid-derived substrates and lipid dependence. Arch. Biochem. Biophys.  320, 210-216 (1995)[Medline].
51. C. F. Bennett, D. L. Spector, and L. C. Yeoman: Nonhistone protein BA is a glutathione S-transferase localized to interchromatinic regions of the cell nucleus. J. Cell Biol.  102, 600-609 (1986)[Abstract/Free Full Text].
52. N. Patel, G. Birner, W. Dekant, and M. W. Anders: Glutathione-dependent biosynthesis and bioactivation of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cystine, the glutathione and cysteine S-conjugates of dichloroacetylene, in rat tissues and subcellular fractions. Drug Metab. Dispos.  22, 143-147 (1994)[Abstract].
53. C. A. Partridge, S. V. Singh, T. D. Hong, C. Theodore, D. D. Dao, and Y. C. Awasthi: Rat lung glutathione S-transferases: subunit structure and the interrelationships with the liver enzymes. Int. J. Biochem.  17, 331-340 (1985)[Medline].
54. S. Anttila, A. Hirvonen, H. Vainio, K. Husgafvel-Pursiainen, J. D. Hayes, and B. Ketterer: Immunocytochemical localization of glutathione S-transferases in human lung. Cancer Res.  53, 5643-5648 (1993)[Abstract/Free Full Text].
55. D. B. Coursin, H. P. Cihla, T. D. Oberley, and L. W. Oberley: Immunolocalization of antioxidant enzymes and isozymes of glutathione S-transferase in normal rat lung. Am. J. Physiol.  263, L679-L691 (1992)[Abstract/Free Full Text].
56. L. M. Pinkus, J. N. Ketley, and W. B. Jakoby: The glutathione S-transferases as a possible detoxication system of rat intestinal epithelium. Biochem. Pharmacol.  26, 2359-2363 (1977)[Medline].
57. G. Clifton and N. Kaplowitz: The glutathione S-transferases of the small intestine in the rat. Cancer Res.  37, 788-791 (1977)[Abstract/Free Full Text].
58. J. M. Daly, L. B. G. Tee, P. S. Oates, R. G. H. Morgan, and C. T. Yeoh: Glutathione S-transferase (µ class) as an early marker of azaserine-induced foci in the rat pancreas. Carcinogenesis  12, 1237-1240 (1991)[Abstract/Free Full Text].
59. C. C. Reddy, C.-P. D. Tu, J. R. Burgess, C.-Y. Ho, R. W. Scholz, and E. J. Massaro: Evidence for the occurrence of selenium-independent glutathione peroxidase activity in rat liver microsomes. Biochem. Biophys. Res. Commun.  101, 970-978 (1981)[Medline].
60. J. P. Veri, L. Hermo, and R. Robaire: Immunocytochemical localization of glutathione S-transferase Yo subunit in the rat testis and epididymis. J. Androl.  15, 415-434 (1994)[Abstract/Free Full Text].
61. S. Papp, B. Robaire, and L. Hermo: Immunocytochemical localization of the Ya, Yc, Yb1, and Yb2 subunits of glutathione S-transferase in the testis and epididymis of adult rats. Microsc. Res. Tech.  30, 1-23 (1995)[Medline].
62. B. Robaire and R. S. Viger: Regulation of epididymal epithelial cell functions. Biol. Reprod.  52, 226-236 (1995)[Abstract].
63. M. Shimoji and Y. Aniya: Glutathione S-transferases in rat testis microsomes: comparison with liver transferase. J. Biochem.  115, 1128-1134 (1994)[Abstract/Free Full Text].
64. W. Dekant, M. W. Anders, and T. J. Monks: Bioactivation of halogenated xenobiotics by S-conjugate formation. In "Renal Disposition and Nephrotoxicity of Xenobiotics" (M. W. Anders, W. Dekant, D. Henschler, H. Oberleithner and S. Silbernagl, eds.), pp. 187-215. Academic Press, San Diego, 1993.
65. M. W. Anders, W. Dekant, and S. Vamvakas: Glutathione-dependent bioactivation of xenobiotics. In "Biothiols" (L. Packer and E. Cadenas, eds.), pp. 135-163. Marcel Dekker, New York, 1995.


Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Y. Ji and B. M. Bennett
Activation of Microsomal Glutathione S-Transferase by Peroxynitrite
Mol. Pharmacol., January 1, 2003; 63(1): 136 - 146.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. B. M. Lantum, R. B. Baggs, D. M. Krenitsky, P. G. Board, and M. W. Anders
Immunohistochemical Localization and Activity of Glutathione Transferase Zeta (GSTZ1-1) in Rat Tissues
Drug Metab. Dispos., June 1, 2002; 30(6): 616 - 625.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. H. Lash and J. C. Parker
Hepatic and Renal Toxicities Associated with Perchloroethylene
Pharmacol. Rev., May 11, 2001; (2001) 2.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. A. Otieno and T. W. Kensler
A Role for Protein Kinase C-{{delta}} in the Regulation of Ornithine Decarboxylase Expression by Oxidative Stress
Cancer Res., August 1, 2000; 60(16): 4391 - 4396.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Dore, M. Takahashi, C. D. Ferris, L. D. Hester, D. Guastella, and S. H. Snyder
Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury
PNAS, March 2, 1999; 96(5): 2445 - 2450.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-J. Jakobsson, J. A. Mancini, D. Riendeau, and A. W. Ford-Hutchinson
Identification and Characterization of a Novel Microsomal Enzyme with Glutathione-dependent Transferase and Peroxidase Activities
J. Biol. Chem., September 5, 1997; 272(36): 22934 - 22939.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. H. Lash and J. C. Parker
Hepatic and Renal Toxicities Associated with Perchloroethylene
Pharmacol. Rev., June 1, 2001; 53(2): 177 - 208.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Otieno, M. A.
Right arrow Articles by Anders, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Otieno, M. A.
Right arrow Articles by Anders, M. W.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition